<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Cancer Urology</journal-id><journal-title-group><journal-title xml:lang="en">Cancer Urology</journal-title><trans-title-group xml:lang="ru"><trans-title>Онкоурология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1726-9776</issn><issn publication-format="electronic">1996-1812</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">303</article-id><article-id pub-id-type="doi">10.17650/1726-9776-2009-5-4-63-67</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ДИАГНОСТИКА И ЛЕЧЕНИЕ ОПУХОЛЕЙ МОЧЕПОЛОВОЙ СИСТЕМЫ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">INFERTILITY AS AN ASPECT OF QUALITY OF LIFE IN CANCER PATIENTS</article-title><trans-title-group xml:lang="ru"><trans-title>БЕСПЛОДИЕ КАК АСПЕКТ КАЧЕСТВА ЖИЗНИ ОНКОЛОГИЧЕСКИХ БОЛЬНЫХ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kostin</surname><given-names>А. А.</given-names></name><name xml:lang="ru"><surname>Костин</surname><given-names>А. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>andocrey@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kaprin</surname><given-names>A. D.</given-names></name><name xml:lang="ru"><surname>Каприн</surname><given-names>А. Д.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>andocrey@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Semin</surname><given-names>A. V.</given-names></name><name xml:lang="ru"><surname>Семин</surname><given-names>А. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>andocrey@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kruglov</surname><given-names>D. P.</given-names></name><name xml:lang="ru"><surname>Круглов</surname><given-names>Д. П.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>Межклиническое отделение андрологии</p></bio><email>andocrey@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Daniyelyan</surname><given-names>A. A.</given-names></name><name xml:lang="ru"><surname>Даниелян</surname><given-names>А. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>andocrey@mail.ru</email><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Russian Cancer Research Center, Russian Agency for Medical Technologies, Moscow</institution></aff><aff><institution xml:lang="ru">ФГУ РНЦР Росмедтехнологий, Москва</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Interclinical Andrology Department,I.M. Sechenov Moscow Medical Academy</institution></aff><aff><institution xml:lang="ru">ММА им. И.М. Сеченова</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">District Military Clinical Hospital No. 442, Leningrad Command, Saint Petersburg</institution></aff><aff><institution xml:lang="ru">ФГУ 442 ОВКГ ЛенВО, Санкт-Петербург</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2009-12-30" publication-format="electronic"><day>30</day><month>12</month><year>2009</year></pub-date><volume>5</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>63</fpage><lpage>67</lpage><history><date date-type="received" iso-8601-date="2014-08-05"><day>05</day><month>08</month><year>2014</year></date><date date-type="accepted" iso-8601-date="2014-08-05"><day>05</day><month>08</month><year>2014</year></date></history><permissions><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://oncourology.abvpress.ru/oncur/article/view/303">https://oncourology.abvpress.ru/oncur/article/view/303</self-uri><abstract xml:lang="en"><p>The paper analyzes the medical and social aspects of infertility in patients diagnosed as having cancer. It provides the populational characteristics of the patients seeking medical advice for infertility. An attempt has been made to study their life history to find out the possible causes of the disease.</p><p> </p></abstract><trans-abstract xml:lang="ru"><p>В статье проанализированы медицинские и социальные аспекты бесплодия применительно к больным с диагнозом «рак». Представлена популяционная характеристика пациентов, обращающихся с проблемой бесплодия, сделана попытка изучить их анамнез жизни для выяснения возможных причин развития заболевания.</p><p> </p></trans-abstract><kwd-group xml:lang="en"><kwd>infertility</kwd><kwd>reproductive health</kwd><kwd>cancer patients</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>бесплодие</kwd><kwd>репродуктивное здоровье</kwd><kwd>онкологические больные</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Fossa S.D., Ous S., Abyholm T., Norman N., Loeb M. Post-treatment fertility in patients with testicular cancer. II. Influence of cis-platin-based combination chemotherapy and of retroperitoneal surgery on hormone and sperm cell production. Br J Urol 1985;57:210—4.</mixed-citation><mixed-citation xml:lang="ru">Fossa S.D., Ous S., Abyholm T., Norman N., Loeb M. Post-treatment fertility in patients with testicular cancer. II. Influence of cis-platin-based combination chemotherapy and of retroperitoneal surgery on hormone and sperm cell production. Br J Urol 1985;57:210—4.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Scheiber K., Bartsch G. Exocrine and endocrine functions in patients with testicular tumors. Prog Clin Biol Res 1985;203:715—24.</mixed-citation><mixed-citation xml:lang="ru">Scheiber K., Bartsch G. Exocrine and endocrine functions in patients with testicular tumors. Prog Clin Biol Res 1985;203:715—24.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Carroll P.R., Morse M.J., Whitmore W.F.J. et al. Fertility status of patients with clinical stage I testis tumors on a surveillance protocol. J Urol 1987;138:70—2.</mixed-citation><mixed-citation xml:lang="ru">Carroll P.R., Morse M.J., Whitmore W.F.J. et al. Fertility status of patients with clinical stage I testis tumors on a surveillance protocol. J Urol 1987;138:70—2.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Jewett M.A., Thachil J.V., Harris J.F. Exocrine function of testis with germinal testicular tumour. Br Med J Clin Res Ed 1983;286:1849—50.</mixed-citation><mixed-citation xml:lang="ru">Jewett M.A., Thachil J.V., Harris J.F. Exocrine function of testis with germinal testicular tumour. Br Med J Clin Res Ed 1983;286:1849—50.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. Fritz K., Weissbach L. Sperm parameters and ejaculation before and after operative treatment of patients with germ-cell testicular cancer. Fertil Steril 1985;43:451—4.</mixed-citation><mixed-citation xml:lang="ru">Fritz K., Weissbach L. Sperm parameters and ejaculation before and after operative treatment of patients with germ-cell testicular cancer. Fertil Steril 1985;43:451—4.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. Horwich A., Nicholls E.J., Hendry W.F. Seminal analysis after orchiectomy in stage I teratoma. Br J Urol 1988;62:79—81.</mixed-citation><mixed-citation xml:lang="ru">Horwich A., Nicholls E.J., Hendry W.F. Seminal analysis after orchiectomy in stage I teratoma. Br J Urol 1988;62:79—81.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7. Nijman J.M., Schraffordt K.H., Kremer J. et al. Fertility and hormonal function in patients with a nonseminomatous tumor of the testis. Arch Androl 1985;14:239—46.</mixed-citation><mixed-citation xml:lang="ru">Nijman J.M., Schraffordt K.H., Kremer J. et al. Fertility and hormonal function in patients with a nonseminomatous tumor of the testis. Arch Androl 1985;14:239—46.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8. Hansen P.V., Trykker H., Andersen J., Helkjaer P.E. Germ cell function and hormonal status in patients with testicular cancer. Cancer 1989;64:956—61.</mixed-citation><mixed-citation xml:lang="ru">Hansen P.V., Trykker H., Andersen J., Helkjaer P.E. Germ cell function and hormonal status in patients with testicular cancer. Cancer 1989;64:956—61.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">9. Drasga R.E., Einhorn L.H., Williams S.D. et al. Fertility after chemotherapy for testicular cancer. J Clin Oncol 1983;1:179—83.</mixed-citation><mixed-citation xml:lang="ru">Drasga R.E., Einhorn L.H., Williams S.D. et al. Fertility after chemotherapy for testicular cancer. J Clin Oncol 1983;1:179—83.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">10. Dearnaley D.P., Horwich A., A'Hern R. et al. Combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for metastatic testicular teratoma: long-term follow-up [see comments]. Eur J Cancer 1991;27:684—91.</mixed-citation><mixed-citation xml:lang="ru">Dearnaley D.P., Horwich A., A'Hern R. et al. Combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for metastatic testicular teratoma: long-term follow-up [see comments]. Eur J Cancer 1991;27:684—91.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">11. Hahn E.W., Feingold S.M., Simpson L. et al. Recovery from aspermia induced by low-dose radiation in seminoma patients. Cancer 1982;50:337—40.</mixed-citation><mixed-citation xml:lang="ru">Hahn E.W., Feingold S.M., Simpson L. et al. Recovery from aspermia induced by low-dose radiation in seminoma patients. Cancer 1982;50:337—40.</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">12. Rowley M.J., Leach D.R., Warner G.A. et al. Effect of graded doses of ionizing radiation on the human testis. Radiat Res 1974;59:665—78.</mixed-citation><mixed-citation xml:lang="ru">Rowley M.J., Leach D.R., Warner G.A. et al. Effect of graded doses of ionizing radiation on the human testis. Radiat Res 1974;59:665—78.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">13. Shalet S.M., Beardwell C.G., Jacobs H.S. et al. Testicular function following irradiation of the human prepubertal testis. Clin Endocrinol (Oxf) 1978;9:483—90.</mixed-citation><mixed-citation xml:lang="ru">Shalet S.M., Beardwell C.G., Jacobs H.S. et al. Testicular function following irradiation of the human prepubertal testis. Clin Endocrinol (Oxf) 1978;9:483—90.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">14. Shalet S.M., Tsatsoulis A., Whitehead E. et al. Vulnerability of the human Leydig cell to radiation damage is dependent upon age. J Endocrinol 1989;120:161—5.</mixed-citation><mixed-citation xml:lang="ru">Shalet S.M., Tsatsoulis A., Whitehead E. et al. Vulnerability of the human Leydig cell to radiation damage is dependent upon age. J Endocrinol 1989;120:161—5.</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">15. Sklar C. Reproductive physiology and treatment-related loss of sex hormone production. Med Pediatr Oncol 1999;33:2—8.</mixed-citation><mixed-citation xml:lang="ru">Sklar C. Reproductive physiology and treatment-related loss of sex hormone production. Med Pediatr Oncol 1999;33:2—8.</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">16. Izard M.A. Leydig cell function and radiation: a review of the literature. Radiother Oncol 1995;34:1—8.</mixed-citation><mixed-citation xml:lang="ru">Izard M.A. Leydig cell function and radiation: a review of the literature. Radiother Oncol 1995;34:1—8.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
